Aralez Pharmaceuticals Revenue and Competitors

Toronto, ON USA

Location

$350M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Aralez Pharmaceuticals's estimated annual revenue is currently $2.4M per year.(i)
  • Aralez Pharmaceuticals's estimated revenue per employee is $100,500
  • Aralez Pharmaceuticals's total funding is $350M.

Employee Data

  • Aralez Pharmaceuticals has 24 Employees.(i)
  • Aralez Pharmaceuticals grew their employee count by -25% last year.

Aralez Pharmaceuticals's People

NameTitleEmail/Phone
1
Senior Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

What Is Aralez Pharmaceuticals?

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. We concentrate mainly on the development phase of a drug's life. We believe that there are and will continue to be more and more opportunities in need of rapid development. Our initial focus is developing products for migraine therapy, a multi-billion dollar global market. POZEN has three product candidates, each designed with a unique profile to treat different stages of migraine attacks - mild, moderate and severe. Combined, these product candidates may offer patients and physicians the ability to customize migraine therapy. We plan to work with partners to commercialize our product candidates, which we project to have a combined market potential of more than $1 billion.

keywords:N/A

$350M

Total Funding

24

Number of Employees

$2.4M

Revenue (est)

-25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aralez Pharmaceuticals News

2022-03-22 - Movers & Shakers, March 25 | BioSpace

Athira Pharma – Michael A. Panzara, M.D., CMO and head of ... roles within Aerie Pharmaceuticals, Aralez Pharmaceuticals and Cubist...

2022-03-22 - Lab Notes: Chimeron's Covid-19 vaccine candidate shows ...

David Enloe, CEO of Societal CDMO (formerly Recro Pharma) ... leadership roles within Aerie Pharmaceuticals, Aralez Pharmaceuticals and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M240%N/A
#2
$2.4M24N/AN/A
#3
$2.5M2519%N/A
#4
N/A2624%N/A
#5
$5.3M260%N/A